ArisGlobal's Innovations Drive AI Success and Client Growth
More than 100 new and expanded LifeSphere customers, launching 34 global implementations, showcase ArisGlobal's robust momentum.
ArisGlobal, a leader in AI technology tailored for life sciences, has declared impressive results for the year as the company underscores its commitment to helping pharmaceutical and life sciences organizations enhance their operations. The year witnessed substantial customer growth, successful worldwide implementations, and an accelerated embrace of its advanced NavaX AI capabilities.
Customer Growth & Expansion
Demand for AI-driven modernization soared in 2025 as organizations sought to navigate increasing data complexities and regulatory challenges. Among the key achievements, the highlights include:
- Over 100 net new customers and expansions linked with LifeSphere activities.
- 125% year-over-year growth in NavaX customer adoption, a testament to its value in Safety and Regulatory.
This rise reflects enhanced customer trust in ArisGlobal's potential to yield decisive outcomes, prompting numerous organizations to expand their engagement beyond initial projects to encompass more integrated uses across domains.
According to Steve Nuckols, Chief Customer Officer, “Customers are not merely experimenting with AI anymore; they are operationalizing it.” He indicated a notable trend: larger-scale deployments and rapid extensions driven by results that matter, such as cycle time reduction and compliance readiness.
Global Implementations and Delivery at Scale
In 2025, ArisGlobal executed an impressive 38 global go-lives, reinforcing its standing in delivering extensive enterprise-level programs:
- 22 projects focused on Safety
- 11 projects centered on Regulatory
- 5 project deployments of NavaX
These initiatives included partnerships with some of the globe's leading pharmaceutical firms and showcased pioneering setups of advanced AI functionalities within the industry.
“Our teams mirror the urgency our customers experience daily,” expressed Raj Hattarki, Chief Operating Officer. “Although these programs involved high complexity worldwide, we accelerated timelines without sacrificing compliance and foundational success.”
Product Innovation: From AI Features to Intelligent Orchestration
Throughout 2025, ArisGlobal achieved significant innovation milestones, evolving LifeSphere from a collection of discrete AI features to a harmonized, intelligence-driven operating framework.
Notable product launches comprised:
- Unify, a data orchestration framework uniting Safety, Regulatory, Quality, and Medical data
- NavaX Insights, converting operational and safety data into actionable insight via real-time analytics
- NavaX Agents, integrating agentic AI into Safety and Regulatory processes
Currently, NavaX services handle approximately 700,000 cases annually, a figure anticipated to rise dramatically to 2.5 million cases in the near future.
The company's innovation was acknowledged with the esteemed Frost & Sullivan 2025 New Product Innovation Award, alongside a pledge to socially responsible AI practices in regulated settings.
“2025 marked a pivotal moment where AI transformed from a theoretical concept into tangible results,” stated Ann-Marie Orange, CIO and Global Head of R&D. “With offerings like NavaX and Unify, our clients are not just automating but also orchestrating data management decisions.”
Looking Forward
With dynamic traction established in 2025, ArisGlobal prepares to enter the new year with a strong focus on amplifying enterprise AI adoption. The aim is to solidify its role as a trusted data intelligence partner for the global life sciences sector.
Aman Wasan, CEO of ArisGlobal, shares this vision: “This year demonstrated the remarkable potential of responsible AI deployment tailored for real-world operations. As AI enters its enterprise maturity, our directive remains focused: intelligent orchestration and fostering trust while delivering meaningful results for patients, regulatory bodies, and operational teams.”
About ArisGlobal
ArisGlobal, at the frontier of AI technology, is redefining how today’s most successful life sciences firms innovate and launch new products. With its headquarters in the U.S., the company maintains a presence in various regions, including Europe and Asia. For more updates, follow ArisGlobal on LinkedIn or explore their offerings at www.arisglobal.com.
Frequently Asked Questions
What was ArisGlobal's growth trend in 2025?
ArisGlobal experienced significant growth with over 100 net new and expanded customers in 2025.
What innovations were introduced by ArisGlobal?
The company introduced several advancements, including Unify and NavaX Insights, enhancing intelligence-driven operating models.
How does NavaX support companies?
NavaX currently processes around 700,000 cases yearly, aiming for a substantial increase to 2.5 million cases by mid-2026.
What awards did ArisGlobal receive in 2025?
ArisGlobal was recognized with the Frost & Sullivan 2025 New Product Innovation Award for its cutting-edge offerings.
What is the focus of ArisGlobal for the future?
Looking ahead, ArisGlobal aims to expand enterprise AI adoption while solidifying its role as a trusted partner in the life sciences sector.
